Lupin-Spektus Deal for DeslaFlex Antidepressant in Canada
February 16, 2026
Lupin signed a licence and supply agreement with Spektus Pharma to commercialise the novel antidepressant DeslaFlex™ in Canada using Spektus’s Flexitab™ platform.
February 16, 2026
Lupin signed a licence and supply agreement with Spektus Pharma to commercialise the novel antidepressant DeslaFlex™ in Canada using Spektus’s Flexitab™ platform.